Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Implitapide is an inhibitor of microsomal triglyceride transfer protein (MTP).
Description | Implitapide is an inhibitor of microsomal triglyceride transfer protein (MTP). |
In vitro | Implitapide inhibits MTP activity using a recombinant human form complexed with protein disulphide isomerase (IC50=10 nM). Implitapide also inhibits the secretion of apoB-containing very low-density lipoprotein (VLDL)-like lipoproteins from a human hepatoma cell (HepG2) (IC50: 1.1 nM)[1]. |
In vivo | Implitapide (3.2 mg/kg/d) markedly inhibits lipid-stained lesions in the mice fed the western-type diet (WD). Implitapide (3.2 mg/kg/d) significantly decreases lesion area by 83% compared with that of the WD group (p<0.01). Implitapide (3.2 mg/kg/d) significantly decreases the plasma lipid levels to nearly or below the chow diet (CD) level at 4 and 8 weeks of treatment (p<0.01). Implitapide at a dosage of approximately 3.2 mg/kg/d significantly reduces the lipid-stained aortic lesions by 83% in apoE KO mice. ApoE KO mice fed a WD containing Implitapide (1, 5, and 15 mg/kg/d) for 14 weeks have been shown to reduce significantly both plaque area (by 66, 78, and 93%, respectively) and lipid moieties within plaque (4.3, 2.6, and 0%, respectively, versus 9.5% in controls)[1]. |
Synonyms | 英普他派, AEGR 427 |
Molecular Weight | 531.69 |
Formula | C35H37N3O2 |
CAS No. | 177469-96-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Implitapide 177469-96-4 代谢 CETP AEGR 427 Inhibitor inhibitor inhibit